+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Real-time PCR Market by Product Type, Technology, Application, End User, Workflow - Global Forecast to 2030- Product Image
Real-time PCR Market by Product Type, Technology, Application, End User, Workflow - Global Forecast to 2030- Product Image
Sale

Real-time PCR Market by Product Type, Technology, Application, End User, Workflow - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012279
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Real-time PCR Market grew from USD 3.76 billion in 2024 to USD 4.13 billion in 2025. It is expected to continue growing at a CAGR of 9.84%, reaching USD 6.61 billion by 2030.

Overview of Real-time PCR’s Strategic Role

Real-time polymerase chain reaction (PCR) stands at the forefront of molecular diagnostics and research, enabling precise quantification of nucleic acids with unparalleled sensitivity and speed. Over the past decade, the integration of advanced enzymatic chemistries, streamlined workflows, and automation platforms has transformed real-time PCR from a specialized technique into a core tool for laboratories across sectors. Today’s real-time PCR systems offer seamless connectivity to laboratory information management systems and cloud-based data analysis environments, empowering researchers and clinicians to generate insights in record time. As the market matures, stakeholders must navigate evolving technological innovations, shifting regulatory landscapes, and dynamic end-user demands. This executive summary synthesizes the critical trends, strategic drivers, and actionable insights shaping the real-time PCR ecosystem, providing decision-makers with a concise overview of the factors driving adoption and growth across applications, geographies, and competitive arenas.

Major Technological and Workflow Evolutions

The real-time PCR landscape has been revolutionized by breakthroughs in digital amplification and probe chemistry innovations. Droplet-based and chip-based digital PCR formats have emerged as game-changers, offering absolute quantification without reliance on standard curves. Meanwhile, refined probe-based chemistries, such as molecular beacons and hydrolysis probes, have elevated assay specificity for detecting single-nucleotide variants and low-abundance transcripts. Alongside these advances, cloud-native data analysis platforms now enable real-time collaboration across distributed teams, accelerating discovery and diagnostics workflows. Automation of sample preparation and amplification has reduced hands-on time, lowered the risk of contamination, and increased throughput in high-demand environments. These shifts not only drive adoption in clinical diagnostics, environmental monitoring, and pharmaceutical development but also expand the addressable market by enabling non-specialist laboratories to implement real-time PCR with confidence and precision.

Navigating 2025 Tariff-Induced Market Adjustments

The introduction of new tariff policies in 2025 has introduced complexity for manufacturers and end users of real-time PCR instruments and consumables in the United States. Import duties on critical reagents and plasticware have incrementally raised input costs, prompting suppliers to recalibrate pricing models and renegotiate supplier contracts. Instrument vendors are offsetting these pressures by localizing production and forging strategic partnerships with domestic component manufacturers to mitigate exposure to import taxes. As a result, lead times for certain consumables have widened, compelling laboratories to adopt more robust inventory management practices. Despite short-term cost increases, these supply chain adjustments are driving investments in domestic manufacturing capacity, which will enhance resilience and reduce vulnerability to future trade policy shifts.

In-Depth Market Segmentation Perspectives

A nuanced understanding of market segments illuminates where growth and differentiation opportunities lie for stakeholders in the real-time PCR industry. Product Type analysis reveals that instruments, reagents and consumables, and software and services form the core areas of focus. Within instruments, integrated systems that combine thermal cycling, fluorescence detection, and data analysis in a single unit are gaining traction among high-throughput laboratories, while standalone thermal cyclers maintain a strong foothold in niche research settings. The reagents and consumables domain is driven by demand for high-fidelity enzymes, optimized master mixes, specialized plasticware designed for low-volume reactions, and curated probe and primer sets tailored to emerging pathogen targets. Software and services continue to expand, encompassing cloud-based solutions for secure data storage, advanced data analysis platforms that integrate machine learning, and service contracts that ensure instrument uptime through preventive maintenance and rapid technical support. From the perspective of technology, digital PCR variants, including chip-based and droplet-based formats, are redefining analytical sensitivity and quantification accuracy, while intercalating dye chemistries offer cost-effective options for gene expression studies. Isothermal amplification techniques provide simple, portable solutions for field diagnostics, and probe-based chemistries-both hydrolysis probes and molecular beacons-facilitate high-specificity detection in multiplexed assays. Application-driven segmentation highlights the pervasive role of real-time PCR in academic research, clinical diagnostics, environmental testing, food safety, agriculture, and the pharmaceutical and biotech industries. Within clinical diagnostics, genetic testing, infectious disease screening, and oncology assays lead adoption, with subdivisions into bacterial, parasitic, and viral testing, as well as gene expression profiling and mutation detection in oncology workflows. End users span academic and research institutes, contract research organizations, diagnostic laboratories both hospital-based and independent, hospitals and clinics across community and tertiary care settings, and pharmaceutical and biotechnology companies invested in drug discovery and development. Finally, the workflow perspective underscores the critical importance of amplification and detection modules, followed by data analysis and interpretation tools such as bioinformatics platforms and software solutions, and sample preparation consumables including extraction kits and purification materials. This comprehensive segmentation framework empowers stakeholders to tailor product portfolios and service offerings to high-value niches and unmet needs.

Regional Market Developments and Drivers

Geographic dynamics reveal distinct growth trajectories and strategic priorities across the Americas, Europe, Middle East and Africa, and Asia-Pacific regions. In the Americas, established healthcare infrastructure and strong investment in academic research drive sustained demand for premium real-time PCR systems and consumables. North American laboratories prioritize integrated platforms and advanced data analytics, whereas Latin American markets show growing interest in cost-effective reagents and field-deployable instruments. Europe, the Middle East and Africa present a diverse landscape: Western European nations demand high-throughput solutions for clinical diagnostics, while emerging economies in Eastern Europe and the Middle East focus on environmental testing and food safety applications. Africa’s expanding public health initiatives are generating increased uptake of portable real-time PCR instruments for infectious disease surveillance. Asia-Pacific markets exhibit rapid adoption driven by expanding biotech sectors in China, India, Japan, and Southeast Asia. Increasing government funding for precision medicine, agricultural biosecurity, and pandemic preparedness programs underpins demand for both core instruments and associated consumables.

Competitive Landscape and Strategic Positioning

Leading players in the real-time PCR space are differentiating themselves through innovation pipelines, strategic alliances, and service excellence. Companies that integrate end-to-end workflow solutions, from sample preparation through data interpretation, are capturing market share by simplifying procurement and support for laboratory customers. Strategic partnerships between instrument manufacturers and software developers are resulting in proprietary analytics platforms that add value through advanced visualization and AI-driven insights. Meanwhile, smaller, specialized firms are carving niches in high-sensitivity digital PCR and novel isothermal chemistries, challenging incumbents with agile product development cycles. Service-oriented companies that offer rapid instrument deployment, comprehensive training, and preventive maintenance contracts are deepening customer relationships and fostering brand loyalty. Additionally, several organizations are investing in local manufacturing and distribution networks to reduce lead times and mitigate trade policy impacts. Intellectual property portfolios, including patents on probe chemistries and thermal cycling algorithms, remain critical assets, driving competitive differentiation and shaping potential merger and acquisition activity.

Strategic Recommendations for Market Leadership

Industry leaders should prioritize several key strategies to thrive in the evolving real-time PCR market. First, investing in modular, scalable platforms will allow vendors to address diverse throughput requirements and accelerate adoption across laboratory types. Second, developing and licensing advanced probe chemistries and digital PCR formats can unlock new applications in rare event detection and single-cell analysis. Third, forging collaborative partnerships with bioinformatics and cloud services providers will enhance data management capabilities, offering customers seamless end-to-end solutions. Fourth, establishing flexible manufacturing footprints, including local production hubs, will reduce vulnerability to future tariff shifts and supply chain disruptions. Fifth, expanding service offerings through comprehensive maintenance and training programs will deepen customer engagement and create recurring revenue streams. Lastly, engaging with regulatory bodies early in the product development cycle will streamline approvals and facilitate market entry for novel assays and platforms.

Robust Multi-Source Research Approach

This analysis is grounded in a multi-phase research methodology that combines primary and secondary data sources to ensure accuracy and relevance. The primary phase involved interviews with key opinion leaders, laboratory directors, procurement specialists, and industry executives to capture firsthand insights into purchasing criteria, workflow challenges, and innovation priorities. Quantitative surveys were administered across representative end-user segments to validate qualitative findings and identify emerging demand signals. The secondary research phase included a thorough examination of peer-reviewed publications, regulatory filings, patent databases, and corporate disclosures to corroborate market trends and technological advancements. Trade data and tariff schedules were analyzed to assess the impact of policy changes on pricing and supply chain dynamics. Data triangulation and expert panel reviews were employed throughout to resolve discrepancies and strengthen the robustness of conclusions. All findings have been cross-validated against recent industry conferences and symposium proceedings to reflect the latest developments.

Synthesis of Market Dynamics and Opportunities

Real-time PCR continues to carve out an indispensable role across scientific, clinical, and industrial domains. The intersections of digital amplification, advanced probe chemistries, and integrated data analytics are setting new benchmarks for sensitivity, speed, and usability. While tariff-induced cost pressures have prompted supply chain adjustments, investments in local manufacturing and partnership-driven innovation are mitigating risks and sustaining growth potential. A detailed segmentation analysis highlights targeted opportunities in instruments, reagents, software, and workflow modules, while regional insights emphasize the distinct needs of laboratories in the Americas, EMEA, and Asia-Pacific regions. Competitive positioning reveals that end-to-end solution providers and nimble specialists each have clear paths to market leadership. Stakeholders who act on the strategic recommendations outlined herein will be well-positioned to capitalize on the transformative advances shaping the real-time PCR landscape.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Instruments
      • Integrated Systems
      • Standalone Systems
    • Reagents & Consumables
      • Enzymes
      • Master Mix
      • Plasticware
      • Probes & Primers
    • Software & Services
      • Cloud-Based Solutions
      • Data Analysis Software
      • Service Contracts & Maintenance
  • Technology
    • Digital PCR
      • Chip-Based Digital PCR
      • Droplet Digital PCR
    • Intercalating Dye Chemistry
    • Isothermal Amplification
    • Probe-Based Chemistry
      • Hydrolysis Probes
      • Molecular Beacons
  • Application
    • Academic Research
    • Clinical Diagnostics
      • Genetic Testing
      • Infectious Disease
        • Bacterial Testing
        • Parasitic Testing
        • Viral Testing
      • Oncology
        • Gene Expression Profiling
        • Mutation Detection
    • Environmental Testing
    • Food Safety & Agriculture
    • Pharma & Biotech
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Diagnostic Laboratories
      • Hospital-Based Laboratories
      • Independent Laboratories
    • Hospitals & Clinics
      • Community Clinics
      • Tertiary Care Hospitals
    • Pharmaceutical & Biotechnology Companies
  • Workflow
    • Amplification & Detection
    • Data Analysis & Interpretation
      • Bioinformatics Tools
      • Software Solutions
    • Sample Preparation
      • Extraction Kits
      • Purification Consumables
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • bioMérieux S.A.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Real-time PCR Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Integrated Systems
8.2.2. Standalone Systems
8.3. Reagents & Consumables
8.3.1. Enzymes
8.3.2. Master Mix
8.3.3. Plasticware
8.3.4. Probes & Primers
8.4. Software & Services
8.4.1. Cloud-Based Solutions
8.4.2. Data Analysis Software
8.4.3. Service Contracts & Maintenance
9. Real-time PCR Market, by Technology
9.1. Introduction
9.2. Digital PCR
9.2.1. Chip-Based Digital PCR
9.2.2. Droplet Digital PCR
9.3. Intercalating Dye Chemistry
9.4. Isothermal Amplification
9.5. Probe-Based Chemistry
9.5.1. Hydrolysis Probes
9.5.2. Molecular Beacons
10. Real-time PCR Market, by Application
10.1. Introduction
10.2. Academic Research
10.3. Clinical Diagnostics
10.3.1. Genetic Testing
10.3.2. Infectious Disease
10.3.2.1. Bacterial Testing
10.3.2.2. Parasitic Testing
10.3.2.3. Viral Testing
10.3.3. Oncology
10.3.3.1. Gene Expression Profiling
10.3.3.2. Mutation Detection
10.4. Environmental Testing
10.5. Food Safety & Agriculture
10.6. Pharma & Biotech
11. Real-time PCR Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.4.1. Hospital-Based Laboratories
11.4.2. Independent Laboratories
11.5. Hospitals & Clinics
11.5.1. Community Clinics
11.5.2. Tertiary Care Hospitals
11.6. Pharmaceutical & Biotechnology Companies
12. Real-time PCR Market, by Workflow
12.1. Introduction
12.2. Amplification & Detection
12.3. Data Analysis & Interpretation
12.3.1. Bioinformatics Tools
12.3.2. Software Solutions
12.4. Sample Preparation
12.4.1. Extraction Kits
12.4.2. Purification Consumables
13. Americas Real-time PCR Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Real-time PCR Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Real-time PCR Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. F. Hoffmann-La Roche AG
16.3.4. Bio-Rad Laboratories, Inc.
16.3.5. QIAGEN N.V.
16.3.6. Agilent Technologies, Inc.
16.3.7. Abbott Laboratories
16.3.8. Becton, Dickinson and Company
16.3.9. PerkinElmer, Inc.
16.3.10. bioMérieux S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. REAL-TIME PCR MARKET MULTI-CURRENCY
FIGURE 2. REAL-TIME PCR MARKET MULTI-LANGUAGE
FIGURE 3. REAL-TIME PCR MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 16. GLOBAL REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL REAL-TIME PCR MARKET SIZE, BY MASTER MIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL REAL-TIME PCR MARKET SIZE, BY PLASTICWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLOUD-BASED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL REAL-TIME PCR MARKET SIZE, BY SERVICE CONTRACTS & MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL REAL-TIME PCR MARKET SIZE, BY INTERCALATING DYE CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL REAL-TIME PCR MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL REAL-TIME PCR MARKET SIZE, BY HYDROLYSIS PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL REAL-TIME PCR MARKET SIZE, BY MOLECULAR BEACONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL REAL-TIME PCR MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL REAL-TIME PCR MARKET SIZE, BY BACTERIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL REAL-TIME PCR MARKET SIZE, BY PARASITIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL REAL-TIME PCR MARKET SIZE, BY VIRAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL REAL-TIME PCR MARKET SIZE, BY MUTATION DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY & AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL REAL-TIME PCR MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL REAL-TIME PCR MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL REAL-TIME PCR MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL REAL-TIME PCR MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL REAL-TIME PCR MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL REAL-TIME PCR MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL REAL-TIME PCR MARKET SIZE, BY AMPLIFICATION & DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL REAL-TIME PCR MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL REAL-TIME PCR MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL REAL-TIME PCR MARKET SIZE, BY EXTRACTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL REAL-TIME PCR MARKET SIZE, BY PURIFICATION CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 108. CANADA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. CANADA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 111. CANADA REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 112. CANADA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. CANADA REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 114. CANADA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 115. CANADA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. CANADA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 117. CANADA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 118. CANADA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 119. CANADA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. CANADA REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 121. CANADA REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 122. CANADA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 123. CANADA REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 124. CANADA REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 125. MEXICO REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. MEXICO REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 129. MEXICO REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 131. MEXICO REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 132. MEXICO REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. MEXICO REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. MEXICO REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 138. MEXICO REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 140. MEXICO REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 141. MEXICO REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 211. GERMANY REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. GERMANY REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 213. GERMANY REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 214. GERMANY REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 215. GERMANY REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. GERMANY REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 217. GERMANY REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 218. GERMANY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. GERMANY REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 221. GERMANY REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 222. GERMANY REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. GERMANY REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 224. GERMANY REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 225. GERMANY REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 226. GERMANY REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 227. GERMANY REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 228. FRANCE REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 231. FRANCE REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. FRANCE REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 234. FRANCE REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 235. FRANCE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. FRANCE REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 237. FRANCE REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 238. FRANCE REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 239. FRANCE REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. FRANCE REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 241. FRANCE REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 242. FRANCE REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 243. FRANCE REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 244. FRANCE REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 262. ITALY REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. ITALY REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 264. ITALY REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 265. ITALY REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 266. ITALY REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. ITALY REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 268. ITALY REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 269. ITALY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. ITALY REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 271. ITALY REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 272. ITALY REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 273. ITALY REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. ITALY REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 275. ITALY REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 276. ITALY REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 277. ITALY REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 278. ITALY REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 279. SPAIN REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. SPAIN REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 281. SPAIN REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 282. SPAIN REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 283. SPAIN REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. SPAIN REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 285. SPAIN REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 286. SPAIN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 290. SPAIN REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. SPAIN REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 292. SPAIN REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 294. SPAIN REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 295. SPAIN REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 320. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 322. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 324. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 330. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 332. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 334. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
TABLE 336. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 339. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 340. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 341. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 343. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 344. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY DATA ANALYSIS & INTERPRETATION, 2018-2030 (USD MILLION)
TABLE 346. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY SAMPLE PREPARATION, 2018-2030 (USD MILLION)
TABLE 347. DENMAR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Real-time PCR market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • bioMérieux S.A.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.13 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.61 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Digital PCR & Real-Time PCR Market by Product Type, Technology, Sample Type, Application, End-User - Global Forecast to 2030 - Product Image

Digital PCR & Real-Time PCR Market by Product Type, Technology, Sample Type, Application, End-User - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
dPCR & qPCR Market by Product Type, Technology, Application, End User - Global Forecast to 2030 - Product Image

dPCR & qPCR Market by Product Type, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Real-time PCR (qPCR) and Digital PCR (dPCR) - Global Strategic Business Report - Product Image

Real-time PCR (qPCR) and Digital PCR (dPCR) - Global Strategic Business Report

  • Report
  • 88 Pages
  • Global
From
PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, QPCR), End-User (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030 - Product Image

PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, QPCR), End-User (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030

  • Report
  • 312 Pages
  • Global
From
Polymerase Chain Reaction - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Polymerase Chain Reaction - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Real Time Polymerase Chain Reaction Market

Real Time Polymerase Chain Reaction (RT-PCR) is a molecular technique used to detect and quantify the presence of specific nucleic acid sequences in a sample. It is a key tool in genomics, allowing researchers to rapidly and accurately measure the expression of genes in a sample. RT-PCR is used in a variety of applications, including gene expression profiling, gene discovery, and disease diagnosis. It is also used to detect and quantify the presence of pathogens, such as viruses and bacteria. RT-PCR is a highly sensitive and specific technique, and is used in a wide range of research and clinical applications. It is a powerful tool for the study of gene expression, and is used to identify and quantify the expression of specific genes in a sample. It is also used to detect and quantify the presence of pathogens, such as viruses and bacteria. RT-PCR is a rapidly growing market, with a wide range of companies offering products and services. Some of the major players in the RT-PCR market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, QIAGEN, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.